All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort

PURPOSE: Reported antibiotic use in coronavirus disease 2019 (COVID-19) is far higher than the actual rate of reported bacterial co- and superinfection. A better understanding of antibiotic therapy in COVID-19 is necessary. METHODS: 6457 SARS-CoV-2-infected cases, documented from March 18, 2020, unt...

Descripción completa

Detalles Bibliográficos
Autores principales: Schons, Maximilian J., Caliebe, Amke, Spinner, Christoph D., Classen, Annika Y., Pilgram, Lisa, Ruethrich, Maria M., Rupp, Jan, Nunes de Miranda, Susana M., Römmele, Christoph, Vehreschild, Janne, Jensen, Bjoern-Erik, Vehreschild, Maria, Degenhardt, Christian, Borgmann, Stefan, Hower, Martin, Hanses, Frank, Haselberger, Martina, Friedrichs, Anette K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500268/
https://www.ncbi.nlm.nih.gov/pubmed/34625912
http://dx.doi.org/10.1007/s15010-021-01699-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500268/
https://www.ncbi.nlm.nih.gov/pubmed/34625912
http://dx.doi.org/10.1007/s15010-021-01699-2

Ejemplares similares